{"id":97,"date":"2025-04-01T15:13:00","date_gmt":"2025-04-01T06:13:00","guid":{"rendered":"https:\/\/demo.themesdaddy.com\/flixita-pro\/?p=97"},"modified":"2025-06-19T09:43:10","modified_gmt":"2025-06-19T00:43:10","slug":"easy-step-for-business-environment","status":"publish","type":"post","link":"https:\/\/www.kr-geninus.com\/?p=97","title":{"rendered":"[2025\/04\/01] Acquire talent for Daiichi Sankyo-CEO"},"content":{"rendered":"\r\n<p><\/p>\r\n<p class=\"\" data-start=\"38\" data-end=\"100\"><!--StartFragment --><\/p>\r\n<p>Geninus, a company specializing in single-cell and spatial omics, announced on the 1st that it has appointed former Korea Daiichi Sankyo CEO Kim Dae-jung as an executive advisor. Kim Dae-jung graduated from Seoul National University&#8217;s College of Pharmacy and later obtained an MBA in Pharma Marketing &amp; Management from Mississippi State University. He gained over 10 years of global experience working in the U.S. Daiichi (now Daiichi Sankyo) branch and Japan&#8217;s headquarters, serving in corporate planning and international business divisions. From April 2008 to March 2023, he led Korea Daiichi Sankyo as its CEO for about 15 years. Following his retirement, he served as an advisor to Korea Daiichi Sankyo and, since July 2023, has been a visiting associate professor at Seoul National University&#8217;s College of Pharmacy. Geninus CEO Park Woong-yang stated, &#8220;With Kim Dae-jung&#8217;s appointment as executive advisor, we expect to strengthen business development with global pharmaceutical companies, particularly in Japan.&#8221; He emphasized that the company will focus on collaborations with Japanese pharmaceutical firms.<\/p>\r\n<p>\u25a0Source:<a href=\"https:\/\/www.biospectator.com\/news\/view\/24710\">BioSpectator<\/a><\/p>\r\n<h4>\ubc15\uc6c5\uc591 \uc9c0\ub2c8\ub108\uc2a4 \ub300\ud45c \u201c\uc77c\ubcf8 \uc81c\uc57d\uc0ac\ub4e4\uacfc \uc0ac\uc5c5\uac1c\ubc1c \uc9d1\uc911\ud560 \uacc4\ud68d\u201d<\/h4>\r\n<p>\uc2f1\uae00\uc140 \ubc0f \uacf5\uac04\uc624\ubbf9\uc2a4 \uc804\ubb38\uae30\uc5c5 \uc9c0\ub2c8\ub108\uc2a4(GENINUS)\ub294 \ud55c\uad6d\ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4 \uae40\ub300\uc911 \uc804 \ub300\ud45c\ub97c \uc0c1\uc784\uace0\ubb38\uc73c\ub85c \ucd08\ube59\ud588\ub2e4\uace0 1\uc77c \ubc1d\ud614\ub2e4. \uae40\ub300\uc911 \uc804 \ub300\ud45c\ub294 \uc11c\uc6b8\ub300\uc57d\ub300\ub97c \uc878\uc5c5\ud558\uace0, \ubbf8\uad6d \ubbf8\uc2dc\uc2dc\ud53c\uc8fc\ub9bd\ub300\ud559\uc5d0\uc11c \ud30c\ub9c8\ub9c8\ucf00\ud305\u00b7\ub9e4\ub2c8\uc9c0\uba3c\ud2b8(Pharma Marketing &amp; Management) \uc804\uacf5\uc73c\ub85c MBA\ub97c \ucde8\ub4dd\ud55c \ub4a4, \ubbf8\uad6d \ub2e4\uc774\uc774\ucc0c(\ud604 \ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4) \uc9c0\uc0ac\uc640 \uc77c\ubcf8 \ubcf8\uc0ac\uc758 \uacbd\uc601\uae30\ud68d\uc2e4 \ubc0f \uad6d\uc81c\uc0ac\uc5c5\ubd80 \ub4f1\uc5d0\uc11c \uadfc\ubb34\ud574 10\uc5ec\ub144\uac04 \uae00\ub85c\ubc8c \uacbd\ud5d8\uc744 \uc313\uc558\ub2e4. \uc774\ud6c4 2008\ub144 4\uc6d4\ubd80\ud130 \ud55c\uad6d\ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4 \ub300\ud45c\uc774\uc0ac\ub85c \ucde8\uc784\ud558\uc5ec 2023\ub144 3\uc6d4\uae4c\uc9c0 \uc57d 15\ub144\uac04 \ud68c\uc0ac\ub97c \uc774\ub04c\uc5c8\ub2e4. \ud1f4\uc784 \ud6c4\uc5d0\ub294 \ud55c\uad6d\ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4\uc758 \uace0\ubb38\uc744 \uc5ed\uc784\ud558\uba74\uc11c, 2023\ub144 7\uc6d4\ubd80\ud130 \uc11c\uc6b8\ub300\uc57d\ub300 \uc81c\uc57d\ud559\uacfc \uac1d\uc6d0\ubd80\uad50\uc218\ub85c \ud65c\ub3d9\ud588\ub2e4. \ubc15\uc6c5\uc591 \uc9c0\ub2c8\ub108\uc2a4 \ub300\ud45c\ub294 \u201c\uae40\ub300\uc911 \uc804 \ub300\ud45c\uc758 \uc0c1\uc784\uace0\ubb38 \uc704\ucd09\uc73c\ub85c \uc77c\ubcf8\uc744 \ube44\ub86f\ud55c \uae00\ub85c\ubc8c \uc81c\uc57d\uc0ac\uc640\uc758 \uc0ac\uc5c5\uac1c\ubc1c\uc5d0 \ud070 \ud798\uc744 \uc2e4\uc744 \uc218 \uc788\uc744 \uac83\uc73c\ub85c \uae30\ub300\ud55c\ub2e4\u201d\uba70 \u201c\uc6b0\uc120 \uc77c\ubcf8 \uc81c\uc57d\uc0ac\ub4e4\uacfc\uc758 \uc0ac\uc5c5\uac1c\ubc1c\uc5d0 \uc9d1\uc911\ud560 \uacc4\ud68d\u201d\uc774\ub77c\uace0 \ub9d0\ud588\ub2e4.<\/p>\r\n<p>\u25a0Source:<a href=\"https:\/\/www.biospectator.com\/news\/view\/24710\">\ubc14\uc774\uc624\uc2a4\ud399\ud14c\uc774\ud130<\/a><\/p>\r\n<p class=\"\" data-start=\"38\" data-end=\"100\"><!--EndFragment --><\/p>\r\n<p>\r\n\r\n<\/p>\r\n\r\n\r\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[37],"tags":[],"class_list":["post-97","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/posts\/97","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=97"}],"version-history":[{"count":21,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/posts\/97\/revisions"}],"predecessor-version":[{"id":1272,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/posts\/97\/revisions\/1272"}],"wp:attachment":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=97"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=97"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=97"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}